RARRES2 and hepatocellular carcinoma: Circulating chemerin levels are reduced in cirrhosis and decline with worsening hepatic function, but paradoxically increase with tumor burden in HCC, sometimes approaching concentrations seen in healthy controls—likely reflecting compensatory release from non-tumorous tissue.